| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B Mullen, J S Brar, A H Vagnucci, R Gangul. Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone. Schizophrenia research. vol 48. issue 1. 2001-05-31. PMID:11345946. |
frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone. |
2001-05-31 |
2023-08-12 |
Not clear |
| R R Conley, R Mahmou. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. The American journal of psychiatry. vol 158. issue 5. 2001-05-24. PMID:11329400. |
a randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. |
2001-05-24 |
2023-08-12 |
Not clear |
| E Spina, A Avenoso, G Facciolà, M Salemi, M G Scordo, M Ancione, A G Madia, E Perucc. Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia. Psychopharmacology. vol 153. issue 2. 2001-05-10. PMID:11205425. |
relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia. |
2001-05-10 |
2023-08-12 |
Not clear |
| S Kooptiwoot, T Settacha. Improvement of tardive dyskinesia with risperidone: a case report. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. vol 83. issue 11. 2001-05-03. PMID:11215878. |
this case report illustrates the improvement of tardive dyskinesia (td) and psychotic symptoms in an elderly thai female with chronic schizophrenia with a long history of conventional antipsychotic exposure following the treatment with risperidone 2 mg/day. |
2001-05-03 |
2023-08-12 |
Not clear |
| T Tanvetyanon, J Dissin, U M Selce. Hyperthermia and chronic pancerebellar syndrome after cocaine abuse. Archives of internal medicine. vol 161. issue 4. 2001-05-03. PMID:11252123. |
the patient had long-standing schizophrenia and had been taking risperidone for 2 years, without evidence of abnormal movements. |
2001-05-03 |
2023-08-12 |
Not clear |
| J Peuskens, B Van Baelen, C De Smedt, P Lemmen. Effects of risperidone on affective symptoms in patients with schizophrenia. International clinical psychopharmacology. vol 15. issue 6. 2001-04-26. PMID:11110010. |
effects of risperidone on affective symptoms in patients with schizophrenia. |
2001-04-26 |
2023-08-12 |
Not clear |
| J Peuskens, B Van Baelen, C De Smedt, P Lemmen. Effects of risperidone on affective symptoms in patients with schizophrenia. International clinical psychopharmacology. vol 15. issue 6. 2001-04-26. PMID:11110010. |
the effects of risperidone on affective symptoms were determined by an analysis of pooled data from six double-blind trials of risperidone versus haloperidol in 1254 patients with chronic schizophrenia. |
2001-04-26 |
2023-08-12 |
Not clear |
| J Peuskens, B Van Baelen, C De Smedt, P Lemmen. Effects of risperidone on affective symptoms in patients with schizophrenia. International clinical psychopharmacology. vol 15. issue 6. 2001-04-26. PMID:11110010. |
these results are consistent with previous reports and suggest that risperidone is more efficacious than haloperidol for affective symptoms in patients with schizophrenia. |
2001-04-26 |
2023-08-12 |
Not clear |
| D J Lang, L C Kopala, R A Vandorpe, Q Rui, G N Smith, V M Goghari, W G Hone. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. The American journal of psychiatry. vol 158. issue 4. 2001-04-26. PMID:11282699. |
an mri study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. |
2001-04-26 |
2023-08-12 |
Not clear |
| D J Lang, L C Kopala, R A Vandorpe, Q Rui, G N Smith, V M Goghari, W G Hone. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. The American journal of psychiatry. vol 158. issue 4. 2001-04-26. PMID:11282699. |
the purpose of this study was to determine the long-term effects of risperidone treatment in a cohort of first-episode patients with schizophrenia. |
2001-04-26 |
2023-08-12 |
Not clear |
| A K Malla, R M Norman, D J Scholten, S Zirul, V Kotted. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. The Journal of clinical psychiatry. vol 62. issue 3. 2001-04-26. PMID:11305704. |
a comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. |
2001-04-26 |
2023-08-12 |
Not clear |
| A K Malla, R M Norman, D J Scholten, S Zirul, V Kotted. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. The Journal of clinical psychiatry. vol 62. issue 3. 2001-04-26. PMID:11305704. |
the present study examines the relative effectiveness of risperidone and typical antipsychotics in patients being treated for their first episode of schizophrenia. |
2001-04-26 |
2023-08-12 |
Not clear |
| N Bhana, R H Foster, R Olney, G L Ploske. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs. vol 61. issue 1. 2001-04-19. PMID:11217867. |
however, preliminary results from an 8-week trial showed comparable cognitive enhancing effects of olanzapine and risperidone treatment in patients with schizophrenia or schizoaffective disorder. |
2001-04-19 |
2023-08-12 |
Not clear |
| N Bhana, R H Foster, R Olney, G L Ploske. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs. vol 61. issue 1. 2001-04-19. PMID:11217867. |
olanzapine treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than haloperidol, and to broadly the same extent as risperidone. |
2001-04-19 |
2023-08-12 |
Not clear |
| P Chue, R Welch, M Snaters. Combination risperidone and quetiapine therapy in refractory schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 46. issue 1. 2001-04-19. PMID:11221496. |
combination risperidone and quetiapine therapy in refractory schizophrenia. |
2001-04-19 |
2023-08-12 |
Not clear |
| I Schweitze. Does risperidone have a place in the treatment of nonschizophrenic patients? International clinical psychopharmacology. vol 16. issue 1. 2001-04-05. PMID:11195255. |
this article reviews the evidence that risperidone may be an effective new treatment for disorders other than schizophrenia. |
2001-04-05 |
2023-08-12 |
Not clear |
| R C Love, M W Nelso. Pharmacology and clinical experience with risperidone. Expert opinion on pharmacotherapy. vol 1. issue 7. 2001-04-05. PMID:11249477. |
risperidone (risperdal, janssen pharmaceutica) is a second generation antipsychotic (sga) for the treatment of schizophrenia and other psychotic disorders. |
2001-04-05 |
2023-08-12 |
Not clear |
| R C Love, M W Nelso. Pharmacology and clinical experience with risperidone. Expert opinion on pharmacotherapy. vol 1. issue 7. 2001-04-05. PMID:11249477. |
in comparison to conventional antipsychotics, risperidone demonstrates superior efficacy against the positive and negative symptoms of schizophrenia and a decreased occurrence of extrapyramidal side effects (eps). |
2001-04-05 |
2023-08-12 |
Not clear |
| E T Edgell, S W Andersen, B M Johnstone, B Dulisse, D Revicki, A Breie. Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia. PharmacoEconomics. vol 18. issue 6. 2001-03-29. PMID:11227395. |
to compare the clinical and economic outcomes associated with olanzapine and risperidone treatment for schizophrenia. |
2001-03-29 |
2023-08-12 |
Not clear |
| M R Dossenbach, P Kratky, M Schneidman, S L Grundy, S Metcalfe, G D Tollefson, R H Belmake. Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone. The Journal of clinical psychiatry. vol 62 Suppl 2. 2001-03-15. PMID:11232749. |
this multicenter, open-label study evaluated the efficacy and safety of olanzapine in patients with schizophrenia who had been nonresponsive or intolerant to a course of risperidone (mean duration of risperidone treatment = 46.3 days). |
2001-03-15 |
2023-08-12 |
Not clear |